Figure 13.

Hypothesis on the mechanism of effect of zerumbone-loaded nanostructured lipid carrier (ZER-NLC) on the canine mammary gland tumor (CMT) adenocarcinoma cells in vitro.

Hypothesis on the mechanism of effect of zerumbone-loaded nanostructured lipid carrier (ZER-NLC) on the canine mammary gland tumor (CMT) adenocarcinoma cells in vitro.